Drugs & Pharmaceuticals

News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.

 I have been writing for years (1) about the emergence and spread of bacteria that are resistant to virtually all antibiotics, and that it was only a matter of time until they reached the US. Time's up.
There's no sign that the ongoing drug overdose epidemic is getting better. In fact, though it has been receiving widespread national attention for about two years, it seems to be getting worse.
Dan Berger, Ph.D. is a former colleague of mine from Wyeth. When Wyeth went away so did we, albeit in different directions.
These are very confusing times for people, especially those without any chemistry training, who are trying to figure out the often confusing and conflicting information about what information toxicology can provide about what drug i
Remember Gilead, that wicked company that dared to cure hepatitis C and made a bunch of money doing so? If this doesn't ring a bell, go back a couple of decades.
More than 42,000 people died in 2016 from an opioid overdose. Forty percent of these deaths involved a prescription opioid.
Blaming your parents for your woes is both trite and whiny. No one wants to hear it.
The American Cancer Society estimates that more than 13,000 cervical cancers will be diagnosed in 2018. Of those, more than 3,000 women will die. 
Would our deceased Presidents fare better today medically than they did in their respective eras? The answer might surprise you.